Flu season is emerging and, although the disease is not predicted to be as prominent as years past, doctors urge people to ...

Free at-home COVID-19 tests are now available for families across the nation. As of Thursday, families are now able to obtain up to four free COVID-19 tests through the U.S. Department of Health and ...

Although COVID-19 has been somewhat controlled, it is still present in forms of different strains, which is why Pfizer, ...

On Thursday, Novavax Inc (NVAX) stock saw a modest uptick, ending the day at $12.9 which represents a slight increase of $0.22 or 1.74% from the prior close of $12.68. The stock opened at $12.6 and ...

1 and the KP.2 strain, have been widely circulating in the United States. Recommendations for the 2024–2025 Novavax vaccine and all 2024–2025 COVID-19 vaccines for children aged 6 months to 11 years ...

Novavax (NVAX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Mayank Mamtani ...

This health news roundup covers various topics including Gerresheimer's stock jump due to an activist investor, a US list of ...

This summary covers recent health events including investment in German firm Gerresheimer, updates on the U.S. Medicare drug ...

Novavax, Inc. (NVAX) announced Wednesday that the European Commission granted Marketing Authorization for Novavax's updated 2024-2025 ...

Novavax said the European Commission has granted marketing authorization for its updated Covid-19 vaccine.

The European Commission authorized Novavax's updated COVID-19 vaccine targeting the JN.1 strain of coronavirus in the region, ...

Fall means it’s time for just about everybody to get up to date on their flu and COVID-19 vaccines – and a lot of older ...